Latest Robert Weinberg Stories
NEW YORK, Jan. 6, 2014 /PRNewswire/ -- Cancer research in the U.S.
Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer cells with a greater ability to migrate and self-renew.
Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC) have updated their seminal review, "Hallmarks of Cancer," which has influenced the study of cancer and the development of therapeutics for more than a decade.
Researchers have synthesized the vast literature on cancer to produce a next-generation view of the features that are shared amongst all cancer cells.
CRANBURY, N.J., Oct. 7 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company, announced today that groundbreaking cancer research scientist Robert A.
A multi-institutional team of Boston-area researchers has discovered a chemical that works in mice to kill the rare but aggressive cells within breast cancers that have the ability to seed new tumors.
A low cellular level of a tiny fragment of RNA appears to increase the spread of breast cancer in mouse models of the disease, according to researchers at Whitehead Institute for Biomedical Research.